美国多中心研究:无肝硬化肝细胞癌的特征、病因与趋势
该研究纳入2000至2014年美国五家大型中心的5144例肝细胞癌患者,其中11.7%无肝硬化。无肝硬化患者中非酒精性脂肪性肝病最常见(26.3%),肿瘤更大且更少符合米兰标准,但接受切除更多且总生存优于肝硬化患者。研究期间无肝硬化肝细胞癌比例下降,而肝硬化肝细胞癌比例上升。
要点
- 无肝硬化肝细胞癌占11.7%,非酒精性脂肪性肝病是最常见病因(26.3%)。
- 无肝硬化患者肿瘤更大(8.9 vs 5.3 cm),更少符合米兰标准(15% vs 39%)。
- 无肝硬化患者接受切除更多(43.6% vs 8%),总生存更优(中位1.8 vs 1.3年)。
核心结论
- 近12%的肝细胞癌发生于无肝硬化患者,非酒精性脂肪性肝病是最常见肝病。
- 研究期间无肝硬化肝细胞癌比例下降,而肝硬化肝细胞癌比例上升。
- 无肝硬化患者虽肿瘤更晚期,但生存优于肝硬化患者。
研究设计与样本
- 2000至2014年美国五家大型中心的多中心研究,纳入5144例肝细胞癌患者。
- 收集患者、肿瘤及肝病病因数据,依据已发表标准评估肝硬化存在。
主要发现
- 无肝硬化患者中非酒精性脂肪性肝病占26.3%,丙型肝炎病毒占12.1%,乙型肝炎病毒占10%。
临床怎么用
- 对于无肝硬化患者,尤其是非酒精性脂肪性肝病者,仍需警惕肝细胞癌风险。
- 无肝硬化肝细胞癌常表现为较大肿瘤且较少符合米兰标准,但切除机会更多。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited data exist on the burden and features of non-cirrhotic hepatocellular carcinoma (HCC) in the United States. AIM: To evaluate characteristics, aetiologies, trends and outcomes of non-cirrhotic HCC from 2000 to 2014 at five large US centres METHODS: Patient, tumour and liver disease aetiology data were collected. The presence of underlying cirrhosis was assessed based on published criteria. RESULTS: Of 5144 eligible patients with HCC, 11.7% had no underlying cirrhosis. Non-cirrhotic patients were older (64.1 vs 61.2 years), more frequently females (33.9% vs 20.8%) and less frequently black (8.3% vs 12.4%) (P < .001 for all). Among non-cirrhotic patients, non-alcoholic fatty liver disease (NAFLD) was the most common liver disease (26.3%), followed by hepatitis C virus (HCV) (12.1%) and hepatitis B virus (HBV) (10%) infections. As of 2014, there was increased percentage of cirrhotic HCC and a decline in non-cirrhotic HCC mainly due to significant annual increases in cirrhotic HCC due to HCV (0.96% [P < .0001]) and NAFLD (0.66% [P = .003]). Patients with non-cirrhotic HCC had larger tumours (8.9 vs 5.3 cm), were less frequently within Milan criteria (15% vs 39%), more frequently underwent resection (43.6% vs 8%) (P < .001 for all) and had better overall survival than cirrhotic HCC patients (median 1.8 vs 1.3 years, P = .004). CONCLUSIONS: Nearly 12% of HCCs occurred in patients without underlying cirrhosis. NAFLD was the most common liver disease in these patients. During the study, the frequency of non-cirrhotic HCC decreased, whereas that of cirrhotic HCC increased. Although non-cirrhotic patients presented with more advanced HCC, their survival was better.
引用
- Gawrieh S, Dakhoul L, Miller E, et al. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Aliment Pharmacol Ther. 2019. PMID: 31475372. doi:10.1111/apt.15464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。